The role of immune checkpoint inhibition in triple negative breast cancer.

Tarekegn K., Keskinkilic M., Kristoff T. J., Evans S. T., Kalinsky K.

Expert review of anticancer therapy, vol.23, pp.1095-1106, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23
  • Publication Date: 2023
  • Doi Number: 10.1080/14737140.2023.2265059
  • Journal Name: Expert review of anticancer therapy
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1095-1106
  • Keywords: Atezolizumab, biomarkers, immune checkpoint inhibitors, immunotherapy, irAE, PD-L1, triple negative breast cancer, pembrolizumab
  • Dokuz Eylül University Affiliated: Yes